These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 36816569)

  • 1. Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries.
    Aychman MM; Goldman DL; Kaplan JS
    Front Neurol; 2023; 14():1087011. PubMed ID: 36816569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
    Yousaf M; Chang D; Liu Y; Liu T; Zhou X
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
    Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
    Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cannabidiol's inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids.
    Ma H; Li H; Liu C; Seeram NP
    J Cannabis Res; 2021 Jun; 3(1):20. PubMed ID: 34162444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
    Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
    Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
    Green R; Khalil R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol Alleviates Neurological Deficits After Traumatic Brain Injury by Improving Intracranial Lymphatic Drainage.
    Dong S; Zhao H; Nie M; Sha Z; Feng J; Liu M; Lv C; Chen Y; Jiang W; Yuan J; Qian Y; Wan H; Gao C; Jiang R
    J Neurotrauma; 2024 Apr; ():. PubMed ID: 38553903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection Following Concussion: The Potential Role for Cannabidiol.
    Singh J; Neary JP
    Can J Neurol Sci; 2020 May; 47(3):289-300. PubMed ID: 32029015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
    Chye Y; Christensen E; Solowij N; Yücel M
    Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
    Pelz MC; Schoolcraft KD; Larson C; Spring MG; López HH
    Epilepsy Behav; 2017 Aug; 73():111-118. PubMed ID: 28624721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of neuroprotective and therapeutic effects of cannabidiol in an acute coronary syndrome model.
    Dogan Unlu M; Uysal D; Karakuyu NF; Asci S; Ozmen O; Tepebasi MY
    Neurosci Lett; 2024 Mar; 825():137689. PubMed ID: 38401641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of cannabidiol's potential targets in limbic seizures.
    Olafuyi O; Kapusta K; Reed A; Kolodziejczyk W; Saloni J; Hill GA
    J Biomol Struct Dyn; 2023; 41(16):7744-7756. PubMed ID: 36129109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.
    Olivas-Aguirre M; Torres-López L; Villatoro-Gómez K; Perez-Tapia SM; Pottosin I; Dobrovinskaya O
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.
    Omotayo OP; Lemmer Y; Mason S
    J Cannabis Res; 2024 Mar; 6(1):14. PubMed ID: 38494488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
    Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.